Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential

Cabotegravir and rilpivirine long-acting injectable antiretroviral therapy for the treatment of HIV-1 infection brings promise of a new mode of delivery and potential solutions to some problems of oral therapy, but also new challenges and unanswered questions. Adding to the increasing body of eviden...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez, Cristina, van Halsema, Clare L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682757/
https://www.ncbi.nlm.nih.gov/pubmed/31447590
http://dx.doi.org/10.2147/HIV.S184642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682757/
https://www.ncbi.nlm.nih.gov/pubmed/31447590
http://dx.doi.org/10.2147/HIV.S184642

Ejemplares similares